BD's Q4 Revenues Down 1 Percent on Currency Effects | GenomeWeb

NEW YORK (GenomeWeb News) – Becton Dickinson today reported $1.97 billion in revenues for its fiscal fourth quarter, down 1 percent from a year ago but in line with the consensus Wall Street estimate.

The company reported revenues of $1.99 billion in the year ago period. On a currency neutral basis revenues were up about 5 percent year over year, BD said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.